CME Group Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CME Group Inc. on September 4, 2013, reporting events occurring on September 4 and September 9, 2013. The filing details the entry into a material definitive agreement regarding a new public debt offering.
Key Financial Metrics and Debt Structure
- Debt Issuance: Completed a public offering of $750,000,000 aggregate principal amount of 5.300% Notes due 2043.
- Issuance Pricing: Notes were sold to underwriters at 98.945% of principal and offered to the public at 99.820% of principal.
- Effective Interest Rate: Due to a forward-starting interest rate swap entered into in August 2012, the effective annual interest rate is estimated at 4.73%.
- Interest Payments: Payable semi-annually on March 15 and September 15, commencing March 15, 2014.
- Use of Proceeds: Intended to retire outstanding 5.75% notes due in February 2014 at maturity, alongside cash on hand. Remaining proceeds may be used for general corporate purposes.
Material Changes and Agreements
The Company entered into an Underwriting Agreement with Barclays Capital Inc., Citigroup Global Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, and Wells Fargo Securities, LLC. Additionally, a Sixth Supplemental Indenture was executed with U.S. Bank National Association as trustee. The Indenture includes covenants limiting the Company's ability to incur certain liens, engage in sale and leaseback transactions, or consolidate/merge assets without restrictions.
Outlook, Risks, and Contingencies
- Redemption Rights: The Company may redeem the Notes prior to March 15, 2043, at 100% of principal plus a make-whole premium. On or after March 15, 2043, redemption is at 100% of principal.
- Change of Control: If a change of control occurs and the Notes are downgraded below investment grade by both Moody's and S&P within a specified period, the Company must offer to repurchase the Notes at 101% of principal plus accrued interest.
- Underwriter Relationships: Underwriters and their affiliates have existing commercial banking, investment banking, and clearing member relationships with the Company, which may involve customary fees and participation in risk committees.
Investor Verification Checklist
- Verify the exact net proceeds received after underwriting discounts and issuance costs.
- Confirm the specific terms of the forward-starting interest rate swap agreement referenced in Item 2.03.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) and Supplemental Indenture (Exhibit 4.2) for detailed covenants and default provisions.
- Monitor the status of the 5.75% notes due February 2014 to confirm the timing of their retirement using the new proceeds.